Patient Square Capital LP Portfolio Holdings

Patient Square Capital LP

  • $267 Billion
  • Q4 2024

Patient Square Capital LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $267 Billion distributed in 20 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Roivant Sciences Ltd. with a value of $148B, Liquidia Corp with a value of $21.9B, Insmed Inc with a value of $21.2B, Cullinan Oncology, Inc. with a value of $10.7B, and Eye Point Pharmaceuticals, Inc. with a value of $10.5B.

Examining the 13F form we can see an decrease of $2.04B in the current position value, from $269B to 267B.

Patient Square Capital LP is based out at Menlo Park, CA

Below you can find more details about Patient Square Capital LP portfolio as well as his latest detailed transactions.

Portfolio value $267 Billion
Healthcare: $259 Billion

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 20
  • Current Value $267 Billion
  • Prior Value $269 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 9 stocks
  • Additional Purchases 9 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2 stocks
Track This Portfolio

Track Patient Square Capital LP Portfolio

Follow Patient Square Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patient Square Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Patient Square Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email